Skip to main content
Equibles

Federation des caisses Desjardins du Quebec

Position in RDY — Dr Reddys Laboratories Ltd

CIK 2022297 LEVIS, A8
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$970,482
+$956,632 QoQ
Shares Held
66,976
+6597.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 238 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Federation des caisses Desjardins du Quebec holds $38,102,659 across 31 Drug Manufacturers - Specialty & Generic names. RDY ranks #9 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 317,729 $10,764,656
2 UTHR
UNITED THERAPEUTICS Corp
 11,689 $6,333,449
3 ZTS
Zoetis Inc.
 85,213 $6,123,404
4 NBIX
Neurocrine Biosciences Inc
 23,904 $4,028,778
5 ANIP
Ani Pharmaceuticals Inc
 31,533 $2,610,301
6 BHC
Bausch Health Companies Inc.
 496,836 $2,449,401
7 VTRS
Viatris Inc
 104,424 $1,658,251
8 ELAN
Elanco Animal Health Inc
 62,505 $1,538,247

All Filings in RDY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $970,482 66,976
2026-03-31 $13,850 1,000
2025-12-31 $298,350 21,250
2025-09-30 $297,075 21,250
2025-06-30 $320,138 21,300
2025-03-31 $280,946 21,300
2024-12-31 $337,258 21,359
2024-09-30 $310,807 3,912
2024-06-30 $282,055 3,702
2024-03-31 $271,541 3,702
2023-09-30 $16,717 250